How to take Capmatinib?

Capmatinib (Capmatinib) is usually taken as an oral tablet and must be taken exactly as prescribed by your doctor. The following is the general usage and dosage, but please note that in actual application, it may be adjusted according to the specific situation of the patient.

1.Dosage: The dosage of capmatinib is determined by the doctor based on the patient's weight, liver function, age, disease status and other factors. Generally, the recommended dose is 400mg twice a day, once in the morning and once in the evening.

2.Taking time: Capmatinib is usually recommended to be taken after meals, that is, within 30 minutes to 1 hours after meals. Food intake can reduce drug irritation to the gastric mucosa and help improve drug absorption. If you are unsure about the best time to take it, ask your doctor or pharmacist.

3.Chewing and Swallowing: Capmatinib tablets should be swallowed whole and should not be chewed or chewed. Swallow the tablets whole with water to ensure the medicine is fully absorbed in the stomach.

4.Follow your doctor’s instructions: Please strictly follow your doctor’s instructions when using capmatinib. Do not increase or decrease the dose at will, and do not discontinue use of the drug unless specifically instructed by your doctor. The dosage and course of treatment should be adjusted according to the patient's condition and response, and regular review and monitoring are required.

5.If you miss a dose: If you miss a dose, take the missed dose as soon as possible, but do not double the dose if it is close to your next dose. If you miss a larger dose or have other questions, talk to your doctor or pharmacist.

6.Adverse reactions: If any adverse reactions or discomfort occur during medication, please report it to your doctor in time. Some common side effects include nausea, vomiting, diarrhea, rash, fatigue, etc. Talking to your doctor can help resolve these issues and ensure your medication is safe.

Capmatinib is a targeted therapy for patients with certain types of non-small cell lung cancer. Before using the drug, genetic testing should first be performed to determine whether the patient is a candidate for capmatinib. At the same time, regular reexamination and monitoring should be carried out during the medication period to evaluate the efficacy and adverse reactions to ensure the safe and effective use of the medication. If you have any questions or need to adjust your medication regimen, please communicate with your doctor promptly.

Capmatinib is not currently on the market in China, so patients cannot purchase it domestically. Capmatinib abroad is divided into original drugs and generic drugs. The original drug is mainly the original drug from Novartis, with a price of about 35,000 yuan and a specification of 200mg*60; the price of generic drugs is very cheap, mainly Laos generic drugs, with a price of about 3,000 to 4,000 yuan. The ingredients of original drugs and generic drugs are basically the same.